NCT06667232 Evaluating Modulation Effects of Burst Stimulation Patterns Using SEEG
| NCT ID | NCT06667232 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-01-18 |
| Primary Completion | 2025-12-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-01-18 with a primary completion date of 2025-12-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to evaluate modulation effects of burst stimulation patterns via SEEG.
Eligibility Criteria
Inclusion Criteria: * Drug-resistant focal epilepsy * Justified SEEG exploration in the context of presurgical assessment of epilepsy * Subjects will be a part of the epilepsy-monitoring unit for long-term SEEG recordings and analysis * Written non-opposition to study participation Exclusion Criteria: * Pregnant women (Contraindication to SEEG exploration) * Psychiatric disorders * History of psychotic disorders * History of cranial trauma serious (according to the classification), previous or evolutionary other neurological pathology * Subjects that experience surgical complications during the implant procedure will be excluded from the study
Contact & Investigator
Liankun Ren, MD
PRINCIPAL INVESTIGATOR
Xuanwu Hospital, Beijing
Frequently Asked Questions
Who can join the NCT06667232 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 65 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06667232 currently recruiting?
Yes, NCT06667232 is actively recruiting participants. Contact the research team at renlk2022@outlook.com for enrollment information.
Where is the NCT06667232 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06667232 clinical trial?
NCT06667232 is sponsored by Xuanwu Hospital, Beijing. The principal investigator is Liankun Ren, MD at Xuanwu Hospital, Beijing. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.